Massachusetts Senate Bill 2520
Session 193rd
An Act relative to pharmaceutical access, costs and transparency
Active
Passed House on Jul 24, 2024
Sponsor
Senate Committee on Bills in the Third Reading
First Action
Nov 15, 2023
Latest Action
Jul 25, 2024
Origin Chamber
Senate
Type
Bill
Bill Number
2520
State
Massachusetts
Session
193rd
Senate Committee on Bills in the Third Reading
grade
Primary
Joint Committee on Health Care Financing
Cosponsor
Senate Committee on Ways and Means
Cosponsor
Senate votes are unavailable for this bill.
Summary
Unavailable
Sort by most recent
07/25/2024
House
Committee of conference appointed - (Lawn-F. Moran-Barrows), in concurrence
07/25/2024
House
House insisted on its amendment
07/25/2024
Senate
Committee on conference (Friedman-Cronin-Tarr), appointed
07/25/2024
Senate
Senate NON-concurred in the House amendment
07/25/2024
Senate
Rules suspended
07/24/2024
House
Passed to be engrossed - 158 YEAS to 0 NAYS (See YEA and NAY, No. 142)
07/24/2024
House
Amended by substitution of a new text (see H4910)
07/24/2024
House
Read third
07/24/2024
House
Rules suspended
07/24/2024
House
Ordered to the third reading
07/24/2024
House
Amendment (as recommended by the committee on House Ways and Means) adopted
07/24/2024
House
Read second
07/24/2024
House
Committee reported that the matter be placed in the Orders of the Day for the next sitting with the amendment pending
07/22/2024
House
Referred to the committee on House Steering, Policy and Scheduling with the amendment pending
07/22/2024
House
Committee recommended ought to pass with an amendment, substituting the text of an amendment, see H4891
11/20/2023
House
Read; and referred to the committee on House Ways and Means
11/15/2023
Senate
Passed to be engrossed -see Roll Call #99 (Yeas 39 to Nays 0)
11/15/2023
Senate
New draft of S2499
11/15/2023
Senate
Reported from the committee on Senate Bills in the Third Reading
Sources
MA Legislature
Open States
Record Created
Nov 16, 2023 8:06:42 AM
Record Updated
Jul 26, 2024 8:09:36 AM